Markets
Stocks
Mutual Funds & ETF's
Sectors
Investing Tools
Overview
Market News
Analysts
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
Local Stocks
BIODEL (NQ: BIOD)
+0.0200 (+0.6024%)
at
3.340
152,884 in Volume
Add to:
My Watchlist
Data as of 05:20 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 3.370
Bid (Size) 3.330 (100)
Ask (Size) 3.340 (300)
Prev. Close 3.320
Today's Range 3.220 - 3.450
52wk Range 3.290 - 6.020
Shares Outstanding 23,883,612
Morningstar Profile
View Full Profile
BIODEL
A specialty biopharmaceutical company, focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes.
Healthcare
Drug Manufacturers - Other
Exchange Traded NQ
Market Cap 79.77M
Related Companies TOS QRXPF ONCMF BSPM
Top News
Read More
Biodel, Inc. (BIOD) Reports First-Quarter Results In Line With Estimates   
Feb 05, 2010
Analyst Pamela Basset at Cantor Fitzgerald has released an update on Biodel, Inc. (NASDAQ: BIOD ). The company reported results for the first-quarter yesterday, which came in line with Cantor... Read More
category Earnings , BIOD , Health Care , and 7 more.
from Benzinga
Biodel Inc. (BIOD) Posts Q4 Loss of $0.47, Wider Y/Y   
Feb 04, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5310715 for the full story. Read More
from StreetInsider.com News Articles
More News
Read More
Biodel reports Q1 EPS (47c) vs. consensus of (43c)   
Feb 04, 2010
category Earnings
from theflyonthewall.com
Biodel Reports First Quarter Fiscal Year 2010 Financial Results
Feb 04, 2010
from Business Wire News Releases
Biodel to Report First Quarter Fiscal Year 2010 Financial Results on February 4, 2010
Feb 01, 2010
from Business Wire News Releases
Biodel new diabetes drugs could add $6 to shares, says Wedbush   
Jan 14, 2010
category Recommendations
from theflyonthewall.com
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
© Copyright FinancialContent, Inc.